<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35282270</PMID><DateRevised><Year>2022</Year><Month>03</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1178-7031</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Journal of inflammation research</Title><ISOAbbreviation>J Inflamm Res</ISOAbbreviation></Journal><ArticleTitle>Elevated TNF-&#x3b1; Induces Thrombophagocytosis by Mononuclear Cells in ex vivo Whole-Blood Co-Culture with Dengue Virus.</ArticleTitle><Pagination><StartPage>1717</StartPage><EndPage>1728</EndPage><MedlinePgn>1717-1728</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/JIR.S356742</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Infection with dengue virus (DENV) causes hematological complications in dengue diseases characterized by thrombocytopenia accompanied by macrophage activation syndrome and hemophagocytosis in fatal patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">In this study, we investigate the undefined mechanisms underlying the progression of thrombocytopenia caused by thrombophagocytosis based on an ex vivo whole-blood co-culture model of DENV infection for mimicking the acute febrile phase of infection.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">In this model, complete blood count test showed a decrease in monocytes (<i>p</i> &lt; 0.01), but not neutrophils nor other white blood cells, accompanied by a low thrombocyte count (<i>p</i> &lt; 0.01) in DENV infection with a positive correlation (<i>r</i> = 0.636, <i>p</i> &lt; 0.05). Furthermore, DENV exposure caused significant thrombophagocytosis in mononuclear cells (<i>p</i> &lt; 0.05). Abnormal production of tumor necrosis factor (TNF)-&#x3b1; was highly associated with induction of thrombophagocytosis (<i>r</i> = 0.758, <i>p</i> &lt; 0.01), decreased monocytes (<i>r</i> = -0.758, <i>p</i> &lt; 0.01), and decreased thrombocyte (<i>r</i> = -0.728, <i>p</i> &lt; 0.01). Neutralizing TNF-&#x3b1; considerably (<i>p</i> &lt; 0.05) reversed such DENV-induced effects and was further validated by immunostaining-based flow cytometry analysis on mononuclear CD14 positive monocytes. Exogenous administration of TNF-&#x3b1; effectively caused thrombophagocytosis accompanied by decreased monocytes and thrombocytes, probably causing monocyte activation.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">These results demonstrate the potential pathogenesis of thrombocytopenia caused by TNF-&#x3b1;-induced thrombophagocytosis in monocytes during DENV infection.</AbstractText><CopyrightInformation>&#xa9; 2022 Satria et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Satria</LastName><ForeName>Rahmat Dani</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Pathology and Laboratory Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Laboratory Installation, Dr. Sardjito Central General Hospital, Yogyakarta, 55281, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 110, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Jhan</LastName><ForeName>Ming-Kai</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, 110, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chia-Ling</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>School of Respiratory Therapy, College of Medicine, Taipei Medical University, Taipei, 110, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tseng</LastName><ForeName>Po-Chun</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Core Laboratory of Immune Monitoring, Office of Research &amp; Development, Taipei Medical University, Taipei, 110, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yung-Ting</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 110, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chiou-Feng</ForeName><Initials>CF</Initials><Identifier Source="ORCID">0000-0003-4396-6086</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Core Laboratory of Immune Monitoring, Office of Research &amp; Development, Taipei Medical University, Taipei, 110, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>J Inflamm Res</MedlineTA><NlmUniqueID>101512684</NlmUniqueID><ISSNLinking>1178-7031</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TNF-&#x3b1;</Keyword><Keyword MajorTopicYN="N">dengue virus</Keyword><Keyword MajorTopicYN="N">ex vivo</Keyword><Keyword MajorTopicYN="N">monocyte</Keyword><Keyword MajorTopicYN="N">thrombophagocytosis</Keyword></KeywordList><CoiStatement>The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>14</Day><Hour>5</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35282270</ArticleId><ArticleId IdType="pmc">PMC8906901</ArticleId><ArticleId IdType="doi">10.2147/JIR.S356742</ArticleId><ArticleId IdType="pii">356742</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Billiau A, Matthys P. Interferon-gamma: a historical perspective. Cytokine Growth Factor Rev. 2009;20(2):97&#x2013;113. doi:10.1016/j.cytogfr.2009.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2009.02.004</ArticleId><ArticleId IdType="pubmed">19268625</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Comprehensive guideline for prevention and control of dengue and dengue haemorrhagic fever; 2011.</Citation></Reference><Reference><Citation>Vogt MB, Lahon A, Arya RP, Spencer Clinton JL, Rico-Hesse R. Dengue viruses infect human megakaryocytes, with probable clinical consequences. PLoS Negl Trop Dis. 2019;13(11):e0007837. doi:10.1371/journal.pntd.0007837</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0007837</ArticleId><ArticleId IdType="pmc">PMC6901235</ArticleId><ArticleId IdType="pubmed">31765380</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu A, Jain P, Gangodkar SV, Shetty S, Ghosh K. Dengue 2 virus inhibits in vitro megakaryocytic colony formation and induces apoptosis in thrombopoietin-inducible megakaryocytic differentiation from cord blood CD34+ cells. FEMS Immunol Med Microbiol. 2008;53:46&#x2013;51. doi:10.1111/j.1574-695X.2008.00399.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-695X.2008.00399.x</ArticleId><ArticleId IdType="pubmed">18371071</ArticleId></ArticleIdList></Reference><Reference><Citation>Sridharan A, Chen Q, Tang KF, Ooi EE, Hibberd ML, Chen J. Inhibition of megakaryocyte development in the bone marrow underlies dengue virus-induced thrombocytopenia in humanized mice. J Virol. 2013;87(21):11648&#x2013;11658. doi:10.1128/JVI.01156-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01156-13</ArticleId><ArticleId IdType="pmc">PMC3807371</ArticleId><ArticleId IdType="pubmed">23966397</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang KJ, Lin YS, Liu HS, Yeh TM, Liu CC, Lei HY. Generation of anti-platelet autoantibody during dengue virus infection. Am J Infect Dis. 2008;4(1):50&#x2013;59. doi:10.3844/ajidsp.2008.50.59</Citation><ArticleIdList><ArticleId IdType="doi">10.3844/ajidsp.2008.50.59</ArticleId></ArticleIdList></Reference><Reference><Citation>Assinger A. Platelets and infection &#x2013; an emerging role of platelets in viral infection. Front Immunol. 2014;5. doi:10.3389/fimmu.2014.00649</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00649</ArticleId><ArticleId IdType="pmc">PMC4270245</ArticleId><ArticleId IdType="pubmed">25566260</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannaioni P, Di Bello M, Masini E. Platelets and inflammation: role of platelet-derived growth factor, adhesion molecules and histamine. Inflamm Res. 1997;46(1):4&#x2013;18. doi:10.1007/PL00000158</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/PL00000158</ArticleId><ArticleId IdType="pubmed">9117517</ArticleId></ArticleIdList></Reference><Reference><Citation>Hottz ED, Medeiros-de-moraes IM, Vieira-de-abreu A, et al. Platelet activation and apoptosis modulate monocyte inflammatory responses in dengue. J Immunol. 2014;193(4):1864&#x2013;1872. doi:10.4049/jimmunol.1400091</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1400091</ArticleId><ArticleId IdType="pmc">PMC4137323</ArticleId><ArticleId IdType="pubmed">25015827</ArticleId></ArticleIdList></Reference><Reference><Citation>Gawaz M, Fateh&#x2010;Moghadam S, Pilz G, Gurland HJ, Werdan K. Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure. Eur J Clin Invest. 1995;25(11):843&#x2013;851. doi:10.1111/j.1365-2362.1995.tb01694.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2362.1995.tb01694.x</ArticleId><ArticleId IdType="pubmed">8582450</ArticleId></ArticleIdList></Reference><Reference><Citation>Dib PRB, Quirino&#x2010;Teixeira AC, Merij LB, et al. Innate immune receptors in platelets and platelet&#x2010;leukocyte interactions. J Leukoc Biol. 2020;108(4):1157&#x2013;1182. doi:10.1002/JLB.4MR0620-701R</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.4MR0620-701R</ArticleId><ArticleId IdType="pubmed">32779243</ArticleId></ArticleIdList></Reference><Reference><Citation>Cognasse F, Nguyen KA, Damien P, et al. The inflammatory role of platelets via their TLRs and Siglec receptors. Front Immunol. 2015;6:83. doi:10.3389/fimmu.2015.00083</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2015.00083</ArticleId><ArticleId IdType="pmc">PMC4345914</ArticleId><ArticleId IdType="pubmed">25784910</ArticleId></ArticleIdList></Reference><Reference><Citation>Kou Z, Quinn M, Chen H, et al. Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells. J Med Virol. 2008;80(1):134&#x2013;146. doi:10.1002/jmv.21051</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.21051</ArticleId><ArticleId IdType="pubmed">18041019</ArticleId></ArticleIdList></Reference><Reference><Citation>Durbin AP, Vargas MJ, Wanionek K, et al. Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. Virology. 2008;376(2):429&#x2013;435. doi:10.1016/j.virol.2008.03.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2008.03.028</ArticleId><ArticleId IdType="pmc">PMC2546568</ArticleId><ArticleId IdType="pubmed">18452966</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhoot MA, Wang SM, Sekaran SD. Inhibition of dengue virus entry and multiplication into monocytes using RNA interference. PLoS Negl Trop Dis. 2011;5(11):e1410. doi:10.1371/journal.pntd.0001410</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001410</ArticleId><ArticleId IdType="pmc">PMC3226553</ArticleId><ArticleId IdType="pubmed">22140591</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikitina E, Larionova I, Choinzonov E, Kzhyshkowska J. Monocytes and macrophages as viral targets and reservoirs. Int J Mol Sci. 2018;19(9):2821. doi:10.3390/ijms19092821</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19092821</ArticleId><ArticleId IdType="pmc">PMC6163364</ArticleId><ArticleId IdType="pubmed">30231586</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong SP, Lee LM, Leong YFI, Ng ML, Chu JJH. Dengue virus infection mediates HMGB1 release from monocytes involving PCAF acetylase complex and induces vascular leakage in endothelial cells. PLoS One. 2012;7(7):e41932. doi:10.1371/journal.pone.0041932</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0041932</ArticleId><ArticleId IdType="pmc">PMC3408393</ArticleId><ArticleId IdType="pubmed">22860034</ArticleId></ArticleIdList></Reference><Reference><Citation>Remy S, Gossez M, Belot A, et al. Massive increase in monocyte HLA-DR expression can be used to discriminate between septic shock and hemophagocytic lymphohistiocytosis-induced shock. Critl Care. 2018;22(1):1&#x2013;2. doi:10.1186/s13054-018-2146-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-018-2146-2</ArticleId><ArticleId IdType="pmc">PMC6131803</ArticleId><ArticleId IdType="pubmed">30205835</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascarella A, Bracaglia C, Caiello I, et al. Monocytes from patients with macrophage activation syndrome and secondary hemophagocytic lymphohistiocytosis are hyperresponsive to interferon gamma. Front Immunol. 2021;12:801. doi:10.3389/fimmu.2021.663329</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.663329</ArticleId><ArticleId IdType="pmc">PMC8010171</ArticleId><ArticleId IdType="pubmed">33815425</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma T, Hudgins JP, Vergara&#x2010;Lluri M, Pham H, Brynes R, Shulman IA. Platelet transfusion refractoriness and thrombophagocytosis in an HIV/AIDS patient with hemophagocytic lymphohistiocytosis. Transfusion. 2020;60:2176&#x2013;2177. doi:10.1111/trf.15955</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.15955</ArticleId><ArticleId IdType="pubmed">32666517</ArticleId></ArticleIdList></Reference><Reference><Citation>Akashi K, Hayashi S, Gondo H, et al. Involvement of interferon&#x2010;&#x3b3; and macrophage colony&#x2010;stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults. Br J Haematol. 1994;87(2):243&#x2013;250. doi:10.1111/j.1365-2141.1994.tb04905.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2141.1994.tb04905.x</ArticleId><ArticleId IdType="pubmed">7947264</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu M, Inoue N, Mizuta M, Nakagishi Y, Yachie A. Characteristic elevation of soluble TNF receptor II: i ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis. Clin Exp Immunol. 2018;191(3):349&#x2013;355. doi:10.1111/cei.13026</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13026</ArticleId><ArticleId IdType="pmc">PMC5801501</ArticleId><ArticleId IdType="pubmed">28815559</ArticleId></ArticleIdList></Reference><Reference><Citation>Billiau AD, Roskams T, Van Damme-lombaerts R, Matthys P, Wouters C. Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-&#x3b3;-producing lymphocytes and IL-6-and TNF-&#x3b1;-producing macrophages. Blood. 2005;105(4):1648&#x2013;1651. doi:10.1182/blood-2004-08-2997</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2004-08-2997</ArticleId><ArticleId IdType="pubmed">15466922</ArticleId></ArticleIdList></Reference><Reference><Citation>Henzan T, Nagafuji K, Tsukamoto H, et al. Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis. Am J Hematol. 2006;81(1):59&#x2013;61. doi:10.1002/ajh.20462</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.20462</ArticleId><ArticleId IdType="pubmed">16369976</ArticleId></ArticleIdList></Reference><Reference><Citation>Ideguchi H, Ohno S, Takase K, et al. Successful treatment of refractory lupus-associated haemophagocytic lymphohistiocytosis with infliximab. Rheumatology. 2007;46(10):1621&#x2013;1622. doi:10.1093/rheumatology/kem205</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kem205</ArticleId><ArticleId IdType="pubmed">17726035</ArticleId></ArticleIdList></Reference><Reference><Citation>McGonagle D, Sharif K, O&#x2019;Regan A, Bridgewood C. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev. 2020;19(6):102537. doi:10.1016/j.autrev.2020.102537</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102537</ArticleId><ArticleId IdType="pmc">PMC7195002</ArticleId><ArticleId IdType="pubmed">32251717</ArticleId></ArticleIdList></Reference><Reference><Citation>Satria RD, Huang T-W, Jhan M-K, et al. Increased TNF-&#x3b1; initiates cytoplasmic vacuolization in whole blood coculture with dengue virus. J Immunol Res. 2021;2021. doi:10.1155/2021/6654617</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6654617</ArticleId><ArticleId IdType="pmc">PMC8121593</ArticleId><ArticleId IdType="pubmed">34041302</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes PR, Rom&#xe3;o-Veiga M, Pera&#xe7;oli JC, et al. Downregulation of CD163 in monocytes and its soluble form in the plasma is associated with a pro-inflammatory profile in pregnant women with preeclampsia. Immunol Res. 2019;67(2&#x2013;3):194&#x2013;201. doi:10.1007/s12026-019-09078-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-019-09078-8</ArticleId><ArticleId IdType="pubmed">31240481</ArticleId></ArticleIdList></Reference><Reference><Citation>Masri MFB, Mantri CK, Rathore AP, John ALS. Peripheral serotonin causes dengue virus&#x2013;induced thrombocytopenia through 5HT2 receptors. Blood. 2019;133:2325&#x2013;2337.</Citation><ArticleIdList><ArticleId IdType="pubmed">30755421</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun DS, King CC, Huang HS, et al. Antiplatelet autoantibodies elicited by dengue virus non&#x2010;structural protein 1 cause thrombocytopenia and mortality in mice. J Thromb Haemost. 2007;5(11):2291&#x2013;2299. doi:10.1111/j.1538-7836.2007.02754.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2007.02754.x</ArticleId><ArticleId IdType="pubmed">17958746</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao C-H, Wu W-C, Lai Y-C, et al. Dengue virus nonstructural protein 1 activates platelets via Toll-like receptor 4, leading to thrombocytopenia and hemorrhage. PLoS Pathog. 2019;15(4):e1007625. doi:10.1371/journal.ppat.1007625</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007625</ArticleId><ArticleId IdType="pmc">PMC6497319</ArticleId><ArticleId IdType="pubmed">31009511</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarice CSH, Abeysuriya V, de Mel S, et al. Atypical lymphocyte count correlates with the severity of dengue infection. PLoS One. 2019;14(5):e0215061. doi:10.1371/journal.pone.0215061</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0215061</ArticleId><ArticleId IdType="pmc">PMC6494037</ArticleId><ArticleId IdType="pubmed">31042724</ArticleId></ArticleIdList></Reference><Reference><Citation>Fadilah S, Sahrir S, Raymond A, Cheong S, Aziz JA, Sivagengei K. Quantitation of T lymphocyte subsets helps to distinguish dengue hemorrhagic fever from classic dengue fever during the acute febrile stage. Southeast Asian J Trop Med Public Health. 1999;30(4):710&#x2013;717.</Citation><ArticleIdList><ArticleId IdType="pubmed">10928365</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi AA, Muneer F. Dynamics of differential count in dengue; 2018.</Citation></Reference><Reference><Citation>Ho T-S, Wang S-M, Lin Y-S, Liu -C-C. Clinical and laboratory predictive markers for acute dengue infection. J Biomed Sci. 2013;20(1):1&#x2013;8. doi:10.1186/1423-0127-20-75</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-20-75</ArticleId><ArticleId IdType="pmc">PMC4015130</ArticleId><ArticleId IdType="pubmed">24138072</ArticleId></ArticleIdList></Reference><Reference><Citation>Achalkar GV. Dengue: a clinico-pathological study of 50 cases. J Evol Med Dent Sci. 2013;2(48):9380&#x2013;9386. doi:10.14260/jemds/1626</Citation><ArticleIdList><ArticleId IdType="doi">10.14260/jemds/1626</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel K, Patel D, Das V. Hematological parameters and its utility in dengue fever: a prospective study. Int J Sci Res. 2016;5:1077&#x2013;1079.</Citation></Reference><Reference><Citation>Azeredo ELD, Monteiro RQ, De-oliveira Pinto LM. Thrombocytopenia in dengue: interrelationship between virus and the imbalance between coagulation and fibrinolysis and inflammatory mediators. Mediators Inflamm. 2015;2015:1&#x2013;16. doi:10.1155/2015/313842</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/313842</ArticleId><ArticleId IdType="pmc">PMC4427128</ArticleId><ArticleId IdType="pubmed">25999666</ArticleId></ArticleIdList></Reference><Reference><Citation>Giang HTN, Banno K, Minh LHN, et al. Dengue hemophagocytic syndrome: a systematic review and meta&#x2010;analysis on epidemiology, clinical signs, outcomes, and risk factors. Rev Med Virol. 2018;28(6):e2005. doi:10.1002/rmv.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2005</ArticleId><ArticleId IdType="pubmed">30109914</ArticleId></ArticleIdList></Reference><Reference><Citation>Srichaikul T, Punyagupta S, Kanchanapoom T, Chanokovat C, Likittanasombat K, Leelasiri A. Hemophagocytic syndrome in Dengue hemorrhagic fever with severe multiorgan complications. J Med Assoc Thai. 2008;91(1):104&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pubmed">18386553</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu P-L, Hsiao -H-H, Tsai -J-J, et al. Dengue virus-associated hemophagocytic syndrome and dyserythropoiesis: a case report. Kaohsiung J Med Sci. 2005;21(1):34&#x2013;39. doi:10.1016/S1607-551X(09)70274-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1607-551X(09)70274-8</ArticleId><ArticleId IdType="pubmed">15754587</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansuini V, Rigante D, Esposito S. Debate around infection-dependent hemophagocytic syndrome in paediatrics. BMC Infect Dis. 2013;13(1):1&#x2013;8. doi:10.1186/1471-2334-13-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-13-15</ArticleId><ArticleId IdType="pmc">PMC3549728</ArticleId><ArticleId IdType="pubmed">23324497</ArticleId></ArticleIdList></Reference><Reference><Citation>Mroczek E, Weisenburger D, Grierson HL, Markin R, Purtilo D. Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome. Arch Pathol Lab Med. 1987;111:530&#x2013;535.</Citation><ArticleIdList><ArticleId IdType="pubmed">3579509</ArticleId></ArticleIdList></Reference><Reference><Citation>Janka G, Imashuku S, Elinder G, Schneider M, Henter J-I. Infection-and malignancy-associated hemophagocytic syndromes: secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am. 1998;12(2):435&#x2013;444. doi:10.1016/S0889-8588(05)70521-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0889-8588(05)70521-9</ArticleId><ArticleId IdType="pubmed">9561911</ArticleId></ArticleIdList></Reference><Reference><Citation>Crayne CB, Albeituni S, Nichols KE, Cron RQ. The Immunology of macrophage activation syndrome. Front Immunol. 2019;10:119. doi:10.3389/fimmu.2019.00119</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00119</ArticleId><ArticleId IdType="pmc">PMC6367262</ArticleId><ArticleId IdType="pubmed">30774631</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo L, Carcillo J. Secondary hemophagocytic lymphohistiocytosis and severe sepsis/systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr Crit Care Med. 2009;10(3):387&#x2013;392. doi:10.1097/PCC.0b013e3181a1ae08</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0b013e3181a1ae08</ArticleId><ArticleId IdType="pubmed">19325510</ArticleId></ArticleIdList></Reference><Reference><Citation>Deane S, Selmi C, Teuber SS, Gershwin ME. Macrophage activation syndrome in autoimmune disease. Int Arch Allergy Immunol. 2010;153(2):109&#x2013;120. doi:10.1159/000312628</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000312628</ArticleId><ArticleId IdType="pubmed">20407267</ArticleId></ArticleIdList></Reference><Reference><Citation>Srikiatkhachorn A, Mathew A, Rothman AL. Immune-mediated cytokine storm and its role in severe dengue. Semin Immunopathol. 2017;39(5):563&#x2013;574. doi:10.1007/s00281-017-0625-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-017-0625-1</ArticleId><ArticleId IdType="pmc">PMC5496927</ArticleId><ArticleId IdType="pubmed">28401256</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangione JN, Huy NT, Lan NTP, et al. The association of cytokines with severe dengue in children. Trop Med Health. 2014;42(4):137&#x2013;144. doi:10.2149/tmh.2014-09</Citation><ArticleIdList><ArticleId IdType="doi">10.2149/tmh.2014-09</ArticleId><ArticleId IdType="pmc">PMC4253061</ArticleId><ArticleId IdType="pubmed">25589878</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Jin C, Zhan F, et al. Host cytokine storm is associated with disease severity of severe fever with thrombocytopenia syndrome. J Infect Dis. 2012;206(7):1085&#x2013;1094. doi:10.1093/infdis/jis452</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jis452</ArticleId><ArticleId IdType="pubmed">22904342</ArticleId></ArticleIdList></Reference><Reference><Citation>Patro A, Mohanty S, Prusty BK, et al. Cytokine signature associated with disease severity in dengue. Viruses. 2019;11(1):34. doi:10.3390/v11010034</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11010034</ArticleId><ArticleId IdType="pmc">PMC6357178</ArticleId><ArticleId IdType="pubmed">30626045</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez&#x2010;Mestre M, Gendzekhadze K, Rivas&#x2010;Vetencourt P, Layrisse Z. TNF&#x2010;&#x3b1;&#x2010;308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients. Tissue Antigens. 2004;64(4):469&#x2013;472. doi:10.1111/j.1399-0039.2004.00304.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0039.2004.00304.x</ArticleId><ArticleId IdType="pubmed">15361124</ArticleId></ArticleIdList></Reference><Reference><Citation>Vejbaesya S, Luangtrakool P, Luangtrakool K, et al. TNF and LTA gene, allele, and extended HLA haplotype associations with severe dengue virus infection in ethnic Thais. J Infect Dis. 2009;199:1442&#x2013;1448. doi:10.1086/597422</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/597422</ArticleId><ArticleId IdType="pmc">PMC2674618</ArticleId><ArticleId IdType="pubmed">19392621</ArticleId></ArticleIdList></Reference><Reference><Citation>Alagarasu K, Mulay A, Singh R, Gavade V, Shah P, Cecilia D. Association of HLA-DRB1 and TNF genotypes with dengue hemorrhagic fever. Hum Immunol. 2013;74(5):610&#x2013;617. doi:10.1016/j.humimm.2013.01.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2013.01.027</ArticleId><ArticleId IdType="pubmed">23380141</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Chen R, Liu J, Kuo H, Kuo H, Yang KD. Implications of dynamic changes among tumor necrosis factor-alpha (TNF-alpha), membrane TNF receptor, and soluble TNF receptor levels in regard to the severity of dengue infection. Am J Trop Med Hyg. 2007;77(2):297. doi:10.4269/ajtmh.2007.77.297</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2007.77.297</ArticleId><ArticleId IdType="pubmed">17690402</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardier JE, Mari&#xf1;o E, Romano E, et al. Proinflammatory factors present in sera from patients with acute dengue infection induce activation and apoptosis of human microvascular endothelial cells: possible role of TNF-&#x3b1; in endothelial cell damage in dengue. Cytokine. 2005;30(6):359&#x2013;365. doi:10.1016/j.cyto.2005.01.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2005.01.021</ArticleId><ArticleId IdType="pubmed">15935956</ArticleId></ArticleIdList></Reference><Reference><Citation>Meena AA, Murugesan A, Sopnajothi S, et al. Increase of plasma TNF-&#x3b1; is associated with decreased levels of blood platelets in clinical dengue infection. Viral Immunol. 2020;33:54&#x2013;60. doi:10.1089/vim.2019.0100</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2019.0100</ArticleId><ArticleId IdType="pubmed">31532346</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur J, Shen Y, Gardiner E, et al. TNF receptor&#x2010;associated factor 4 (TRAF4) is a novel binding partner of glycoprotein Ib and glycoprotein VI in human platelets. J Thromb Haemost. 2011;9(1):163&#x2013;172. doi:10.1111/j.1538-7836.2010.04091.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2010.04091.x</ArticleId><ArticleId IdType="pubmed">20946164</ArticleId></ArticleIdList></Reference><Reference><Citation>Inwald DP, McDowall A, Peters MJ, Callard RE, Klein NJ. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res. 2003;92(9):1041&#x2013;1048. doi:10.1161/01.RES.0000070111.98158.6C</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000070111.98158.6C</ArticleId><ArticleId IdType="pubmed">12676820</ArticleId></ArticleIdList></Reference><Reference><Citation>Piguet PF, Vesin C, Da Kan C. Activation of platelet caspases by TNF and its consequences for kinetics. Cytokine. 2002;18(4):222&#x2013;230. doi:10.1006/cyto.2002.0889</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/cyto.2002.0889</ArticleId><ArticleId IdType="pubmed">12126645</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart PH, Hunt EK, Bonder CS, Watson CJ, Finlay-Jones JJ. Regulation of surface and soluble TNF receptor expression on human monocytes and synovial fluid macrophages by IL-4 and IL-10. J Immunol. 1996;157(8):3672&#x2013;3680.</Citation><ArticleIdList><ArticleId IdType="pubmed">8871669</ArticleId></ArticleIdList></Reference><Reference><Citation>Langstein J, Michel J, Fritsche J, Kreutz M, Andreesen R, Schwarz H. CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling. J Immunol. 1998;160(5):2488&#x2013;2494.</Citation><ArticleIdList><ArticleId IdType="pubmed">9498794</ArticleId></ArticleIdList></Reference><Reference><Citation>Leeuwenberg J, Dentener MA, Buurman WA. Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein. The. J Immunol. 1994;152:5070&#x2013;5076.</Citation><ArticleIdList><ArticleId IdType="pubmed">7513728</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>